Abstract
Pancreatic exocrine insufficiency and a reduction in the volume of the pancreas on computed tomography developed in two patients after more than 24 months of sorafenib therapy.
Cite
CITATION STYLE
APA
Hescot, S., Vignaux, O., & Goldwasser, F. (2013). Pancreatic Atrophy — A New Late Toxic Effect of Sorafenib. New England Journal of Medicine, 369(15), 1475–1476. https://doi.org/10.1056/nejmc1305302
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free